logo

For the Inventor, By the Inventor

Stow, MA, United States of America

Andrew Cook

This inventor holds 22 USPTO granted patents and 7 published patent applications and 1 EPO patent, primarily in Biopharmaceutical Development. Top assignees: Constellation Pharmaceuticals, Inc., Eisai R&d Management Co., Ltd., Axovant Sciences Gmbh. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Cook. Retrieved from https://idiyas.com/inventor/andrew-cook

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 59.1

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 41(Granted Patents)


Location History:

  • Jackson, MI (US) (2015)
  • Fort Erie, CA (2021)
  • Stow, MA (US) (2015 - 2024)

Company Filing History:

goldMedal6 out of 56 
 
Constellation Pharmaceuticals, Inc.
 patents
silverMedal6 out of 530 
 
Eisai R&d Management Co., Ltd.
 patents
bronzeMedal3 out of 8 
 
Axovant Sciences Gmbh
 patents
4. 2 out of 13 
 
Eisai R&D Management Co., Ltd.
 patents
5. 1 out of 57 
 
Denali Therapeutics Inc.
 patents
6. 4 out of 834,601 
Other
 patents

Years Active: 2015-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Pladienolides
PPARg Modulators
Antibody-Drug Conjugates
Splicing Modulators
Aminobenzisoxazole
Nicotinic Receptors
Methyl Modifying Enzymes
Oxadiazine Compounds
Concrete Manipulation
Ceiling Suspension
Hanger Systems
Three-Dimensional Structure
22 patents (USPTO):Explore Patents
1. 12622905 - ARYL PLADIENOLIDES FOR THE TREATMENT OF NEOPLASTIC DISORDERS (2026-05-12),
2. 12606541 - PPARg modulators and methods of use (2026-04-21),
3. 12514926 - SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE (2026-01-06),
4. 12172986 - Splicing modulator antibody-drug conjugates and methods of use (2024-12-24),
5. 11945807 - Splicing modulator antibody-drug conjugates and methods of use (2024-04-02),
6. 11926619 - Certain pladienolide compounds and methods of use (2024-03-12),
7. 11679107 - Certain aryl pladienolide compounds and methods of use (2023-06-20),
8. 11352348 - Splicing modulator antibody-drug conjugates and methods of use (2022-06-07),
9. 11084188 - Three-dimensional structure and method and system of making same (2021-08-10),
10. 11008755 - Ceiling system and hanger for suspending ceiling tiles or panels therefrom (2021-05-18),
11. 10941569 - Clip hanger and ceiling suspension system incorporating same (2021-03-09),
12. 10428062 - Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors (2019-10-01),
13. 10370370 - Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors (2019-08-06),
14. 10183938 - Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors (2019-01-22),
15. 10016405 - Modulators of methyl modifying enzymes, compositions and uses thereof (2018-07-10),

Certainly! Here is an article about inventor Andrew Cook:

Title: Unveiling the Inventive Mind of Andrew Cook

Introduction:

Andrew Cook, a prolific inventor hailing from Stow, MA (US), has made significant contributions to the field of oncology through his innovative patents and groundbreaking research. With an impressive portfolio of 14 patents, Andrew Cook continues to revolutionize the landscape of cancer therapeutics.

Latest Patents:

Andrew Cook's latest patents include the development of Splicing Modulator Antibody-Drug Conjugates and novel Pladienolide compounds. These cutting-edge inventions focus on enhancing the efficacy of cancer treatments by targeting human oncology targets and utilizing splicing modulator drug moieties.

Career Highlights:

Throughout his career, Andrew Cook has been associated with reputable companies such as Constellation Pharmaceuticals, Inc. and Eisai R&D Management Co., Ltd. He has spearheaded research projects aimed at advancing the forefront of oncology treatments and has been instrumental in translating scientific discoveries into practical applications.

Collaborations:

Andrew Cook has had the pleasure of working alongside esteemed colleagues such as Brian K Albrecht and James E Audia. Their collaborative efforts have resulted in the development of innovative therapeutic strategies and have laid the foundation for future advancements in the field of cancer research.

Conclusion:

In conclusion, Andrew Cook's relentless pursuit of innovation and his unwavering dedication to improving cancer therapeutics have solidified his position as a trailblazer in the realm of oncology. His pioneering patents and collaborative endeavors underscore his commitment to driving progress and delivering impactful solutions to combat neoplastic disorders.Dot

Let me know if you need more information or if there is anything else I can assist you with.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…